Disease Course and Outcomes in Patients With the Limited Form of Neuromyelitis Optica Spectrum Disorders and Negative AQP4-IgG Serology at Disease Onset: A Prospective Cohort Study
Open Access
- 1 January 2022
- journal article
- research article
- Published by XMLink in Journal of Clinical Neurology
- Vol. 18 (4) , 453-462
Abstract
Chen X, et al. J Clin Neurol. 2022 Jul;18(4):453-462. https://doi.org/10.3988/jcn.2022.18.4.453Keywords
Funding Information
- National Natural Science Foundation of China (81771300, 81971140)
- Natural Science Foundation of Guangdong Province (2020A1515010053)
- Norman Bethune Foundation (2020009)
This publication has 30 references indexed in Scilit:
- Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)Journal of Neurology, 2013
- Serologic diagnosis of NMONeurology, 2012
- Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4Multiple Sclerosis Journal, 2011
- Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritisJournal of the Neurological Sciences, 2010
- EFNS guidelines on diagnosis and management of neuromyelitis opticaEuropean Journal of Neurology, 2010
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- NMO-IgG predicts the outcome of recurrent optic neuritisNeurology, 2008
- Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosisBrain, 2007
- Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 ExpressionArchives of Neurology, 2006
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006